Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Finn

Showing results (101-110 of 407) with videos related to

Pageof 41
Sort By:
Seminars in Immunology|June 17, 2010
Cancer vaccines: the state of the artOlivera Olja J Finn, Jacques Banchereau
Advances in Immunology|January 1, 1996
Human tumor antigens are ready to flyR A Henderson, O J Finn
Frontiers in Immunology|February 22, 2020
Editorial: Myeloid Derived Suppressor Cells as Disease ModulatorsOlivera J Finn, Augusto C Ochoa
Cold Spring Harbor Perspectives in Biology|December 20, 2017
Is It Possible to Develop Cancer Vaccines to Neoantigens, What Are the Major Challenges, and How Can These Be Overcome? Neoantigens: Nothing New in Spite of the NameOlivera J Finn, Hans-Georg Rammensee
Journal of Food Protection|June 19, 2019
Survival of Pathogens on Modified-Atmosphere-Packaged Shredded Carrot and CabbageMary J Finn, Mary E Upton
Biochemical and Biophysical Research Communications|October 29, 1987
Antibodies that recognize phosphodiester-linked amino-N-acetylglucosamine-1-phosphate residuesD J Finn, G L Gustafson
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 1, 2020
The evolutionary puzzle of Escherichia coli ST131Johann D D Pitout, Thomas J Finn
Cancer Research|April 3, 2008
MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1Katja Engelmann, Hongmei Shen, Olivera J Finn
Australian Dental Journal|January 24, 2004
Efficacy of cardiopulmonary resuscitation performed in a dental chairA J Lepere, J Finn, I Jacobs
Molecular Immunology|May 16, 2002
Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53Min Yu, Qimin Zhan, Olivera J Finn
Pageof 41

Showing results (101-110 of 407) with videos related to

Sort By:
Pageof 41
Seminars in Immunology|June 17, 2010
Cancer vaccines: the state of the artOlivera Olja J Finn, Jacques Banchereau
Advances in Immunology|January 1, 1996
Human tumor antigens are ready to flyR A Henderson, O J Finn
Frontiers in Immunology|February 22, 2020
Editorial: Myeloid Derived Suppressor Cells as Disease ModulatorsOlivera J Finn, Augusto C Ochoa
Cold Spring Harbor Perspectives in Biology|December 20, 2017
Is It Possible to Develop Cancer Vaccines to Neoantigens, What Are the Major Challenges, and How Can These Be Overcome? Neoantigens: Nothing New in Spite of the NameOlivera J Finn, Hans-Georg Rammensee
Journal of Food Protection|June 19, 2019
Survival of Pathogens on Modified-Atmosphere-Packaged Shredded Carrot and CabbageMary J Finn, Mary E Upton
Biochemical and Biophysical Research Communications|October 29, 1987
Antibodies that recognize phosphodiester-linked amino-N-acetylglucosamine-1-phosphate residuesD J Finn, G L Gustafson
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 1, 2020
The evolutionary puzzle of Escherichia coli ST131Johann D D Pitout, Thomas J Finn
Cancer Research|April 3, 2008
MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1Katja Engelmann, Hongmei Shen, Olivera J Finn
Australian Dental Journal|January 24, 2004
Efficacy of cardiopulmonary resuscitation performed in a dental chairA J Lepere, J Finn, I Jacobs
Molecular Immunology|May 16, 2002
Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53Min Yu, Qimin Zhan, Olivera J Finn
Pageof 41